Hypertension, Vol 22, 467-478, Copyright © 1993 by American Heart Association
K Pacak, G Yadid, G Jakab, JW Lenders, IJ Kopin and DS Goldstein
Juvenile spontaneously hypertensive rats (SHR) have higher plasma levels of
catechols and markedly larger catechol responses to yohimbine than do
normotensive Wistar-Kyoto rats, indicating increased sympathoadrenal
outflow and increased alpha 2-adrenergic receptor- mediated restraint of
peripheral catecholamine release during hypertension development in SHR.
Yohimbine-induced catecholamine release and metabolism in the
posterolateral hypothalamus of the brain were assessed in juvenile (6 to 7
weeks) and adult (15 to 16 weeks) SHR and Wistar-Kyoto rats. In vivo
microdialysis was used to obtain samples for measurements of
norepinephrine, dihydroxyphenylglycol, methoxyhydroxyphenylglycol, and
dihydroxyphenylacetic acid in conscious animals before and after yohimbine
injection (1 mg/kg IV) beginning 24 hours after probe implantation.
Catecholamine synthesis was examined from elevations of
3,4-dihydroxyphenylalanine levels after probe perfusion with NSD-1015, an
inhibitor of L-aromatic acid decarboxylase. In adults, SHR had higher
dialysate norepinephrine (277 +/- 38 versus 181 +/- 35 pg/mL),
dihydroxyphenylglycol (3260 +/- 509 versus 2231 +/- 201 pg/mL),
methoxyhydroxyphenylglycol (2659 +/- 369 versus 1890 +/- 144 pg/mL), and
dihydroxyphenylacetic acid (46,312 +/- 5512 versus 13,187 +/- 1963 pg/mL)
levels and markedly larger increases in 3,4- dihydroxyphenylalanine levels
after NSD-1015 than Wistar-Kyoto rats. In juveniles, SHR had larger
proportionate increments in microdialysate norepinephrine levels after
yohimbine than Wistar-Kyoto rats (85% versus 25%). Although juvenile SHR
and Wistar-Kyoto rats had similar NSD-1015-elicited increments in
3,4-dihydroxyphenylalanine levels, systemic yohimbine enhanced the
NSD-1015-elicited 3,4- dihydroxyphenylalanine elevations in juvenile SHR
but not in Wistar- Kyoto rats. These findings suggest augmented
norepinephrine release and catecholamine synthesis in the posterolateral
hypothalamus of adult SHR and augmented alpha 2-adrenergic receptor
restraint of both norepinephrine release and catecholamine synthesis in
juvenile SHR.
ARTICLES
In vivo hypothalamic release and synthesis of catecholamines in spontaneously hypertensive rats
Clinical Neuroscience Branch, National Institute of Neurological Disorders and Stroke, Bethesda, Md. 20892.
This article has been cited by other articles:
![]() |
S. Kasparov and A. G. Teschemacher Altered central catecholaminergic transmission and cardiovascular disease Exp Physiol, June 1, 2008; 93(6): 725 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Gironacci, M. S. Valera, I. Yujnovsky, and C. Pena Angiotensin-(1-7) Inhibitory Mechanism of Norepinephrine Release in Hypertensive Rats Hypertension, November 1, 2004; 44(5): 783 - 787. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. De Wardener The Hypothalamus and Hypertension Physiol Rev, October 1, 2001; 81(4): 1599 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jacobson Lower Weight Loss and Food Intake in Protein-Deprived, Corticotropin Releasing Hormone-Deficient Mice Correlate with Glucocorticoid Insufficiency Endocrinology, August 1, 1999; 140(8): 3543 - 3551. [Abstract] [Full Text] |
||||
![]() |
D. Ely, A. Caplea, G. Dunphy, H. Daneshvar, M. Turner, A. Milsted, and M. Takiyyuddin Spontaneously Hypertensive Rat Y Chromosome Increases Indexes of Sympathetic Nervous System Activity Hypertension, February 1, 1997; 29(2): 613 - 618. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |